Inspire Medical Systems Cash on Hand 2017-2026 | INSP
Inspire Medical Systems cash on hand from 2017 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Inspire Medical Systems Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $308 |
| 2024 | $446 |
| 2023 | $460 |
| 2022 | $451 |
| 2021 | $214 |
| 2020 | $234 |
| 2019 | $149 |
| 2018 | $188 |
| 2017 | $16 |
|
Inspire Medical Systems Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $321 |
| 2026-03-31 | $284 |
| 2025-12-31 | $308 |
| 2025-09-30 | $323 |
| 2025-06-30 | $301 |
| 2025-03-31 | $369 |
| 2024-12-31 | $446 |
| 2024-09-30 | $411 |
| 2024-06-30 | $440 |
| 2024-03-31 | $441 |
| 2023-12-31 | $460 |
| 2023-09-30 | $464 |
| 2023-06-30 | $467 |
| 2023-03-31 | $452 |
| 2022-12-31 | $451 |
| 2022-09-30 | $428 |
| 2022-06-30 | $196 |
| 2022-03-31 | $203 |
| 2021-12-31 | $214 |
| 2021-09-30 | $210 |
| 2021-06-30 | $208 |
| 2021-03-31 | $226 |
| 2020-12-31 | $234 |
| 2020-09-30 | $235 |
| 2020-06-30 | $243 |
| 2020-03-31 | $136 |
| 2019-12-31 | $149 |
| 2019-09-30 | $152 |
| 2019-06-30 | $159 |
| 2019-03-31 | $177 |
| 2018-12-31 | $188 |
| 2018-09-30 | $120 |
| 2018-06-30 | $124 |
| 2018-03-31 | $18 |
| 2017-12-31 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.157B | $0.912B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |